Dr. Seneviratne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1245 Wilshire Blvd
Suite 303
Los Angeles, CA 90017Phone+1 213-977-1214Fax+1 213-482-8868- Is this information wrong?
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2000 - 2001- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1999 - 2000
- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1998 - 1999
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Colombo Faculty of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1996 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.Thomas Stricker, Neha Jain, Esprit Ma, Elaine Yu, Rongrong Wang, Robert Schuldt, Richard Price, Tania Szado, Jesse Sussell, Sarika Ogale, Victor Lin, Edward Arrowsmith...> ;The Oncologist. 2024 Feb 28
- Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.Lee Schwartzberg, Davey Daniel, Dennis Slater, Harry Staszewski, Bruno Fang, Lasika Seneviratne, Elaine Yu, Richard Price, Tania Szado, Craig S Meyer, Anuj Shah, Espri...> ;Future Oncology. 2023 Jun 1
- 22 citationsRandomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)David R. Spigel, Robert M. Jotte, John Nemunaitis, Merrill Kingman Shum, Jeffrey A. Schneider, Jerome H. Goldschmidt, Jennifer L. Eisenstein, David Berz, Lasika Senevi...> ;Journal of Thoracic Oncology. 2021 Feb 1
- Join now to see all
Press Mentions
Data at 2020 ASCO Virtual Scientific Program Demonstrates Strength of Nucleix’s Six-Marker Methylation-Based Assay Detecting Broad Array of Early CancersMay 26th, 2020
Professional Memberships
- Member
Hospital Affiliations
California Hospital Medical CenterLos Angeles, California
Adventist Health GlendaleGlendale, California- PIH Health Good Samaritan HospitalLos Angeles, California
UCI HealthOrange, California
St. Mary Medical Center Long BeachLong Beach, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
